Deals & Corporate Governance

  • January 05, 2024

    IQVIA Drops Healthcare Ad Deal After Court Pause

    Healthcare data company IQVIA has abandoned its planned purchase of Propel Media after the Federal Trade Commission convinced a court to pause the deal over concerns about the cost of advertising that targets doctors and other healthcare professionals.

  • January 05, 2024

    Healthcare-Focused PE Firm Closes $180M Fund

    Healthcare-focused private equity shop Leavitt Equity Partners, advised by Dorsey & Whitney LLP, on Friday said that it closed its third private equity fund after raising $180 million in commitments.

  • January 05, 2024

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen Lucasfilm use the force in a High Court appeal in a dispute over the use of the late actor Peter Cushing's likeness, defunct crypto lender Celsius bring legal proceedings against cryptocurrency insurance startup Unslashed, and the Kuwaiti pensions authority bring another lawsuit to the table in a $10 million bribery scandal involving the authority’s former boss. Here, Law360 looks at these and other new claims in the U.K.

  • January 04, 2024

    Roche Could Pay $2B In Deal To Develop Potent Cancer Drugs

    Moma Therapeutics announced Thursday that it could receive over $2 billion in milestone payments from Swiss pharmaceutical giant Roche through a new collaboration to develop powerful cancer treatments.

  • January 04, 2024

    Life Sciences Investment Firm TCG Crossover Closes $1B Fund

    TCG Crossover, also known as TCGX, announced Thursday that it has closed a new fund, raising $1 billion in capital to be invested into both private and public companies focused on drug discovery.

  • January 04, 2024

    Hospital Network Told To Provide Contracts In Antitrust Suit

    A Connecticut state judge Thursday ordered Hartford HealthCare Corp. to hand over a raft of contracts with insurers and related documents, some dating back to 2008, as part of a discovery request in a putative class action accusing the hospital network of violating antitrust and unfair trade practices laws.

  • January 04, 2024

    Chancery Rejects Injunction Barring SomaLogic Merger Vote

    Finding that risks to a $1 billion merger outweigh disputed stockholder claims of inadequate disclosures and an unfair process, a Delaware vice chancellor on Thursday refused to block a noon shareholder vote on the tie-up between SomaLogic Inc. and Standard BioTools Inc.

  • January 04, 2024

    Deals Rumor Mill: Cigna, Bain Capital, Amazon

    Cigna is seeking to unload its Medicare Advantage business for up to $4 billion, Bain Capital wants to sell antibodies manufacturer Centrient Pharmaceuticals for $1.1 billion, and Amazon could buy a stake in regional sports networks. Here, Law360 breaks down these and other notable deal rumors from the past week.

  • January 04, 2024

    Medical Tech Co. Buys Breathing Device Biz For Up To $2.5M

    Inspiration Healthcare Group PLC said Thursday that it has bought life support ventilator business Airon Corp. in a deal worth up to $2.5 million, as the British medical technology company eyes entering the "significant strategic market" in the U.S.

  • January 03, 2024

    ACTS Retirement Data Breach Suit Settlement Gets Initial OK

    A Pennsylvania federal judge gave preliminary approval Tuesday to a deal inked by ACTS Retirement Services Inc. to settle claims it failed to protect the personal information of nearly 21,000 people exposed in an April 2022 data breach.

  • January 03, 2024

    5 January Argument Sessions Benefits Attys Should Watch

    The Fifth Circuit will hear arguments this month over whether the Affordable Care Act's anti-discrimination mandate covers sexual orientation and gender identity, and Goldman Sachs workers will seek to revive a class action over proprietary retirement investments.

  • January 03, 2024

    No Fines Over Physician Retirement Offer, HHS OIG Says

    A health system that makes voluntary offers to all physician partners reaching the age of 67 to purchase their partnership units if they stop practicing medicine does not breach the federal Anti-Kickback Statute, the U.S. Department of Health and Human Services said in an advisory opinion posted Wednesday.

  • January 03, 2024

    Chancery Mulls Call To Block $1B SomaLogic Merger

    A Delaware vice chancellor reported plans to rule Thursday morning on a preliminary injunction bid from a proposed class of stockholders targeting the merger of SomaLogic Inc. and Standard BioTools Inc., hours before a noon Eastern time stockholder meeting on the hotly contested biopharmaceutical industry tie-up.

  • January 03, 2024

    Esperion Snags $125M Deal With Daiichi On Cholesterol Drug

    Esperion Therapeutics Inc. on Wednesday announced a $125 million deal with a Japanese pharmaceutical giant to resolve Esperion's demand for $300 million from the company over Esperion's cholesterol reduction drugs.

  • January 03, 2024

    Hartford HealthCare Wants Contracts Left Out Of Antitrust Suit

    Hartford HealthCare Corp. should not have to hand over even more confidential insurer contracts to a putative class of policyholders or be forced to make them public as part of an antitrust suit, counsel for the Connecticut hospital network told a state judge Wednesday.

  • January 03, 2024

    Polsinelli Hires Real Estate Lawyer From Caddis

    BigLaw firm Polsinelli PC has added a shareholder to its real estate and financial services team in Denver who will bring a wealth of experience advising clients both as an in-house attorney and in private practice.

  • January 02, 2024

    Myovant, Sumitomo Beat Investor Suit Over Skadden Advice

    Sumitomo Pharma America Inc. and Myovant Sciences Ltd. have escaped for good a proposed class action alleging the companies' merger was undervalued because the lawyers from Skadden Arps Slate Meagher & Flom LLP who helped negotiate the deal had undisclosed conflicts of interest.

  • January 02, 2024

    Health Service Co., Oncology Firm Kick-Start 2024 IPO Filings

    Private-equity backed healthcare platform BrightSpring Health Services Inc. and bladder-cancer therapy company CG Oncology Inc. filed initial public offering plans on Tuesday, the first companies to join this year's IPO pipeline, under the combined guidance of three law firms.

  • January 02, 2024

    Failed Negotiation Leaves Prisma Hospitals Out Of UHC Network

    Eighteen South Carolina hospitals are now out-of-network providers for UnitedHealthcare customers, the insurer announced Tuesday, saying Prisma Health Facilities caused the change by refusing to budge on its "unsustainable" 20% price hikes during contract negotiations.

  • January 02, 2024

    UK Biopharmaceutical Biz Raises $260M In Series C Funding

    British biopharmaceutical company Apollo Therapeutics revealed Tuesday that it completed a second close of its Series C financing round last month, bringing the total amount raised in the funding round over the course of 2023 to $260 million.

  • January 02, 2024

    Catching Up With Delaware's Chancery Court

    Delaware's busy Court of Chancery barely stopped to take a break at the end of 2023, keeping the courtroom open for hearings on Carvana and Meta, pushing out year-end decisions related to Fox Corp., Oracle and AmerisourceBergen, and making way for new cases involving biomedical venture SomaLogic Inc., U.S. Bancorp, and Capital Square Partners merger target Startek Inc.

  • January 02, 2024

    FTC Wins Pause Of IQVIA Healthcare Ad Deal

    A New York federal court has granted the Federal Trade Commission's request to pause IQVIA's planned purchase of Propel Media for an in-house agency challenge over concerns about competition in the digital healthcare advertising industry.

  • January 02, 2024

    Pa. Court Rejects Red Book Drug Prices For Workers' Comp

    A Pennsylvania appellate court found Tuesday that the Red Book pricing values used by the state's Bureau of Workers' Compensation to determine fair repayment for injured workers' prescription drugs is inconsistent with state law and ordered the agency to find a new way to calculate those costs.

  • January 02, 2024

    Lab Workers Were Fired Lawfully, Mich. Hospital Says

    A Michigan hospital urged a federal judge to reject a National Labor Relations Board official's bid to reinstate 12 lab workers fired for staging a walkout during an organizing drive, claiming the union ignored the National Labor Relations Act's requirement for hospitals to be notified of walkouts in advance.

  • January 02, 2024

    UPMC Hit With OT Class Suit By Respiratory Therapist

    The University of Pittsburgh Medical Center's Harrisburg hospital and a staffing company have been misclassifying respiratory therapists as independent contractors and cheating them out of overtime wages, a former worker alleged in a proposed class action in Pennsylvania state court.

Expert Analysis

  • 4 Ways State Oversight May Change Nationwide Health Deals

    Author Photo

    With California soon to become the most recent state to increase its oversight of health care mergers, acquisitions and investments, attorneys should consider how these updated state regulations may increase the costs, timelines and disclosure requirements for national deals, say John Saran and Jaclyn Freshman at Ropes & Gray.

  • Could The Supreme Court Legalize Marijuana Federally?

    Author Photo

    Amid slow legislative and executive movement on cannabis reform, it’s worth examining whether the U.S. Supreme Court could provide a pathway to federal cannabis legalization — a decision that would surely require strange bedfellows given the court’s current ideological makeup, say Whitt Steineker and Mason Kruse at Bradley Arant.

  • Establishing A Record Of Good Faith In Mediation

    Author Photo

    Viacom v. U.S. Specialty Insurance, and other recent cases, highlight the developing criteria for determining good faith participation in mediation, as well as several practical tips to establish such a record, says Richard Mason at MasonADR.

  • ABA Opinion Should Help Clarify Which Ethics Rules Apply

    Author Photo

    A recent American Bar Association opinion provides key guidance on interpreting ABA Model Rule 8.5's notoriously complex choice-of-law analysis — and should help lawyers authorized to practice in multiple jurisdictions determine which jurisdiction's ethics rules govern their conduct, say attorneys at HWG.

  • How Cannabis Cos. Can Keep Up With Privacy Compliance

    Author Photo

    With the cannabis industry's rapid growth and access to sensitive consumer information, and the ever-changing patchwork of state data privacy laws, it is becoming increasingly important for marijuana businesses to treat cybersecurity as a significant risk and management priority, say attorneys at Goodwin.

  • 4 Ways To Reboot Your Firm's Stalled Diversity Program

    Author Photo

    Law firms that have failed to see real progress despite years of diversity initiatives can move forward by committing to tackle four often-taboo obstacles that hinder diversity, equity and inclusion efforts, says Steph Maher at Jaffe.

  • DOJ's Google Sanctions Motion Shows Risks Of Auto-Deletion

    Author Photo

    The U.S. Department of Justice recently hit Google with a sanctions motion over its alleged failure to preserve relevant instant-messaging communications, a predicament that should be a wake-up call for counsel concerning the danger associated with automatic-deletion features and how it's been handled by the courts, say Oscar Shine and Emma Ashe at Selendy Gay.

  • What To Expect From A Litigation Finance Industry Recession

    Author Photo

    There's little data on how litigation finance would fare in a recession, but a look at stakeholders' incentives suggests corporate demand for litigation finance would increase in a recessionary environment, while the number of funders could shrink, says Matthew Oxman at LexShares.

  • J&J Unit Ch. 11 Case Shows Texas 2-Step May Be Wrong Move

    Author Photo

    The Third Circuit's recent ruling in the Chapter 11 case of Johnson & Johnson's talc-related damages unit raises new questions about the viability of divisional merger transactions as a means to manage mass tort liabilities through bankruptcy, especially when there is a robust funding arrangement, say attorneys at Mayer Brown.

  • Del. Ruling Could Affect D&O Claims Beyond SPACs

    Author Photo

    A Delaware state court recently held in Clover Health v. Berkley Insurance that directors and officers of a post-merger entity were insured persons under a special-purpose acquisition company's D&O policy, a ruling that could have potential ramifications for future D&O claims in Delaware outside of SPAC deals, say Geoffrey Fehling and Janine Hanrahan at Hunton.

  • Breaking Down Maryland's Adult-Use Cannabis Bill

    Author Photo

    Maryland voters approved adult-use cannabis in November and state lawmakers have recently introduced a bill to create a regulatory framework for its cultivation, production and sale, but questions remain on blackout periods for licensees, vertical integration, a lack of protection for off-the-job marijuana use and more, say attorneys at Fox Rothschild.

  • The Limits Of Arbitration Provisions In The ERISA Context

    Author Photo

    Although courts have viewed the Federal Arbitration Act as strongly favoring the enforcement of arbitration provisions, two recent decisions from the District of Delaware and the Tenth Circuit demonstrate that arbitration provisions that expressly forbid planwide relief are not likely to be enforced in ERISA cases seeking such relief, says Elizabeth Hopkins at Kantor & Kantor.

  • Justices Leave Questions Open On Dual-Purpose Atty Advice

    Author Photo

    The U.S. Supreme Court's recent dismissal of In re: Grand Jury on grounds that certiorari was improvidently granted leaves unresolved a circuit split over the proper test for deciding when attorney-client privilege protects a lawyer's advice that has multiple purposes, say Susan Combs and Richard Kiely at Holland & Hart.